Our mission has been to award projects that save lives
As Prof. June says, “The journey of CAR-T is a story of persistence, of radical collaboration and, most importantly, of the profound courage of the patients who enroll in our trials.
Our mission has been to award projects that save lives
As Prof. June says, “The journey of CAR-T is a story of persistence, of radical collaboration and, most importantly, of the profound courage of the patients who enroll in our trials.
Today, on World Health Day, we celebrate our 2025 BMIA Laureates, Prof. June and Prof. Sadelain, and their groundbreaking innovation: CAR-T cell therapy!
This year’s theme, “Together for health. Stand with science”, highlights exactly what their work represents –how collaboration and scientific excellence can transform patient care and save lives.
#WorldHealthDay #StandWithScience #MedicalInnovation #CARTCellTherapy #BMIA #Healthcare #Research
#cancer #cancerresearch #cancercure
CAR T-Cell Therapy Cost in India - HOSPISITY
CAR T-Cell Therapy is an advanced immunotherapy that uses genetically modified T-cells to target and destroy cancer cells with precision. The CAR T-Cell Therapy Cost in India typically ranges from $45,000 to $85,000, making it significantly more affordable compared to Western countries.
#CART-CellTherapyCostinIndia
#CARTcelltherapy
Know More: https://hospisity.com/treatments/car-t-cell-therapy-cost-in-india/
Are Western wait times and costs putting CAR-T cell therapy out of reach?
Discover how Medical Tourism China offers global patients faster 36-hour cell manufacturing and 70% lower costs. MedBridgeNZ is your trusted medical concierge provider—we handle the travel, translation, and hospital access logistics (no direct medical services provided), connecting you to world-class care.
Read the ultimate patient guide here:
https://zurl.co/JzGrg

Key Takeaways • Significant Cost Reductions: Commercial CAR-T treatments in China can cost over 70% less than in the United States, with clinical trial options potentially lowering medical expenses even further. • Rapid Manufacturing Speed: Advanced automated platforms in China have condensed the cell manufacturing cycle from several weeks to just 24-36 hours, preventing disease progression during wait times. • Expedited Access: China’s "Dual-Track" regulatory system allows top-tier hospitals to
When six-year-old Emily Whitehead was diagnosed with leukemia that no treatment could stop, Carl June & his team at the University of Pennsylvania believed there was another way.
They reprogrammed her immune cells to recognize & destroy cancer — creating the first successful CAR T-cell therapy.
Today, that breakthrough has given thousands of patients a second chance at life.
#cartcelltherapy #immunotherapy #leukemia #childhoodcancer #cancertreatment #cancercure